Differential growth inhibition of cultured mammalian cells: Comparison of clinical antitumour agents and amsacrine derivatives
- 1 March 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (3) , 383-389
- https://doi.org/10.1016/0277-5379(84)90085-3
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Divergent activity of derivatives of amsacrine (m-AMSA) towards Lewis lung carcinoma and P388 leukaemia in miceEuropean Journal of Cancer and Clinical Oncology, 1983
- The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, ledakrin or nitracrine, with DNA and other macromolecules of mammalian or bacterial cellsChemico-Biological Interactions, 1983
- Antitumour activity of substituted 9-anilinoacridines—Comparison of in vivo and in vitro testing systemsPublished by Elsevier ,1981
- DNA double-strand breaks in mammalian cells after exposure to intercalating agentsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1981
- 4′-(9-Acridinylamino) Methanesulfon-m-Anisidide (AMSA): A New Drug Effective in the Treatment of Adult Acute LeukemiaAnnals of Internal Medicine, 1980
- Improved immune-suppression techniques for the xenografting of human tumoursBritish Journal of Cancer, 1978
- GENERAL MECHANISM FOR MICROSOMAL ACTIVATION OF QUINONE ANTI-CANCER AGENTS TO FREE-RADICALS1978
- In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stainExperimental Cell Research, 1977
- The cytotoxic action of carcinolytic agents in tissue cultureThe American Journal of Medicine, 1956